Skip to main content
SpringerLink
Log in

Enhancement of Bone Growth by Sustained Delivery of Recombinant Human Bone Morphogenetic Protein-2 in a Polymeric Matrix

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The purpose of this study was to develop a polymeric sustained delivery system for recombinant human bone morphogenetic protein-2 (BMP-2) and to evaluate local bone growth induced by the sustained release of BMP-2 in an animal model.

Methods. BMP-2 was incorporated in biodegradable poly(D,L-lactide-co-glycolide) (PLGA) microspheres to obtain different release rates. Two sustained and an immediate release implants were produced by suspending the BMP-2 loaded PLGA microspheres in aqueous sodium carboxymethylcellulose (CMC), lyophilizing, and cutting the dried materials to the size of the animal bone defects. The local in vivo release at the implantation site in rat calvarial defects was determined by gamma scintigraphy using radiolabeled BMP-2. The local bone induction in the critical size of rabbit calvarial defects was evaluated six weeks post implantation.

Results. The immediate release implant showed about 65% initial drug release within 24 h and the remaining BMP-2 quickly exhausted from the implantation site within 7 days. The sustained release implants, showing 45-55% initial release followed by a prolonged release for 21 days, released a greater amount of BMP-2 at the implantation site and maintained higher serum BMP-2 for the longer period of time compared to the immediate release implant. Significant bone growth was observed in all BMP-2 treated defects while the defects without treatment or with BMP-2-free implant showed minimal bone healing. 75-79% of rabbit calvarial defect area was healed with newly induced bone matrix by the sustained release implants in 6 weeks as compared to 45% recovery from the immediate release implant.

Conclusion. The sustained delivery of BMP-2 based on the biodegradable PLGA microsphere system resulted in faster and more complete bone healing in the animal model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. R. A. Kenley, K. Yim, J. Abrams, E. Ron, T. Turek, L. J. Marden, and J. O. Hollinger. Biotechnology and bone graft substitutes. Pharm. Res. 10:1393-1401 (1993).

    Google Scholar 

  2. P. J. Boyne, R. E. Marx, M. Nevins, G. Triplett, E. Lazaro, L. C. Lilly, M. Alder, and P. Nummikoski. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int. J. Periodont. Rest. Dent. 17:11-25 (1997).

    Google Scholar 

  3. U. Ripamonti, M. Heliotis, D. C. Rueger, and T. K. Sampath. Induction of cementogenesis by recombinant human osteogenic protein-1(hop-1/bmp-7) in the baboon (Papio ursinus). Arch. Oral. Biol. 41:121-126 (1996).

    Google Scholar 

  4. A. J. Celeste, J. A. Iannazzi, R. C. Taylor, R. M. Hewick, V. Rosen, E. A. Wang, and J. M. Wozney. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. USA 87:9843-9847 (1990).

    Google Scholar 

  5. E. A. Wang. Bone morphogenetic proteins (BMPs): the therapeutic potential in healing bony defects. Trends Biotechnol. 11:379-383 (1993).

    Google Scholar 

  6. E. Özkaynak, D. C. Rueger, E. A. Drier, C. Corbett, R. J. Ridge, T. K. Sampath, and H. Oppermann. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J. 9:2085-2093 (1990).

    Google Scholar 

  7. T. K. Sampath, J. E. Coughlin, R. M. Whetstone, D. Banach, C. Corbett, R. J. Ridge, E. Ozkaynak, and H. Oppermann. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J. Biol. Chem. 265:13198-13205 (1990).

    Google Scholar 

  8. E. Özkaynak, P. N. Schnegelsberg, D. F. Jin, G. M. Clifford, F. D. Warren, E. A. Drier, and H. Oppermann. Osteogenic protein-2: A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. J. Biol. Chem. 267:25220-25227 (1992).

    Google Scholar 

  9. K. Elima. Osteoinductive proteins. Ann. Med. 25:395-402 (1993).

    Google Scholar 

  10. K. Tagaki and M. R. Urist. The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann. Surg. 196:100-109 (1982).

    Google Scholar 

  11. V. Rosen and R. S. Thies. The BMP proteins in bone formation and repair. Trends Genet. 8:97-102 (1992).

    Google Scholar 

  12. A. H. Reddi and N. S. Cunningham. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J. Bone Miner. Res. 8:S499-S502 (1993).

    Google Scholar 

  13. E. A. Wang, D. I. Israel, S. Kelly, and D. P. Luxenberg. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9:57-71 (1993).

    Google Scholar 

  14. I. Ono, T. Ohura, M. Murata, H. Yamaguchi, Y. Ohnuma, and Y. Kuboki. A study on bone induction in hydroxyapatite combined with bone morphogenetic protein. Plast. Reconstr. Surg. 90:870-879 (1992).

    Google Scholar 

  15. J. P. Levine, J. Bradley, A. E. Turk, J. L. Ricci, J. J. Benedict, G. Steine, M. T. Longaker, and J. G. McCarthy. Bone morphogenetic protein promotes vascularization and osteoinduction in preformed hydroxyapatite in the rabbit. Ann. Plast. Surg. 39:158-168 (1997).

    Google Scholar 

  16. A. W. Yasko, J. M. Lane, E. J. Fellinger, V. Rosen, J. M. Wozney, and E. A. Wang. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biochemical study in rats. J. Bone Joint Surg. AM. 74:659-670 (1992).

    Google Scholar 

  17. B. A. Doll, H. J. Towle, J. O. Hollinger, A. H. Reddi, and J. T. Mellonig. The osteogenic potential of two composite graft systems using osteogenin. J. Periodontol. 61:745-750 (1990).

    Google Scholar 

  18. J. C. Moore, V. J. Matukas, J. R. Deatherage, and E. J. Miller. Craniofacial osseous restoration with osteoinductive proteins in a collagenous delivery system. Int. J. Oral Maxillofac Surg. 19:172-176 (1990).

    Google Scholar 

  19. H. D. Zegzula, D. C. Buck, J. Brekke, J. M. Wozney, and J. O. Hollinger. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J. Bone Joint Surg. AM. 79:1778-1790 (1997).

    Google Scholar 

  20. T. Miki, K. Harada, Y. Imai, and S. Enomoto. Effect of freezedried poly-L-lactic acid discs mixed with bone morphogenetic protein on the healing of rat skull defects. J. Oral Maxillofac. Surg. 25:387-391 (1994).

    Google Scholar 

  21. R. Kenley, L. Marden, T. Turek, L. Jin, E. Ron, and J. O. Hollinger. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J. Biomed. Mater. Res. 28:1139-1147 (1994).

    Google Scholar 

  22. S. S. Duggirala, R. C. Mehta, and P. P. DeLuca. Interaction of recombinant morphogenetic protein-2 with poly (d,l-lactide-co-glycolide) microspheres. Pharm. Dev. Technol. 1:11-19 (1996).

    Google Scholar 

  23. J. A. Schrier and P. P. DeLuca. Porous bone morphogenetic protein-2 microspheres: Polymer binding and in vitro release. Pharm. Sci. Tech. 2(3) article 17 (2001) [http://www.pharmscitech.com]

  24. Z. Schwartz, A. Somers, J. T. Mellonig, D. L. Carnes Jr, J. M. Wozney, D. D. Dean, D. L. Cochran, and B. D. Boyan. Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material. J. Peridontol. 69:1337-1345 (1998).

    Google Scholar 

  25. D. A. Puleo, W. W. Huh, S. S. Duggirala, and P. P. DeLuca. In vitro cellular response to bioerodible particles loaded with recombinant human morphogenetic protein-2. J. Biomed. Mater. Res. 41:104-110 (1998).

    Google Scholar 

  26. D. A. Puleo. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro. J. Cell. Physiol. 173:93-101 (1997).

    Google Scholar 

  27. J. A. Schrier and P.P. DeLuca. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems. Pharm. Dev. Technol. 4:611-621 (1999).

    Google Scholar 

  28. S. S. Duggirala, J. B. Rodgers, and P. P. DeLuca. The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2. Pharm. Dev. Technol. 1:165-174 (1996).

    Google Scholar 

  29. J. A. Schrier, B. F. fink, J. B. Rodgers, H. C. Vasconez, and P. P. DeLuca. Effect of freeze-dried CMC/PLGA migrosphere matrix of BMP-2 on bone healing. Pharm. Sci. Tech. 2(3) article 18 (2001).

    Google Scholar 

  30. H. Uludag, W. Friess, D. Williams, T. Porter, G. Timony, D. D'Augusta, C. Blake, R. Palmer, B. Biron, and J. Wozney. rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics. Ann. NY Acad. Sci. 875:369-378 (1999).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, 40536

    Byung Ho Woo, Richard Page, Yeong Woo Jo, Ge Jiang, Michelle DeLuca & Patrick P. DeLuca

  2. Division of Plastic Surgery, Department of Surgery, College of Medicine, University of Kentucky, Lexington, Kentucky, 40536

    Betsy F. Fink & Henry C. Vasconez

  3. Biotechnology Facility, Magellan Laboratories, Inc., San Diego, California, 92126

    Jay A. Schrier

Authors
  1. Byung Ho Woo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Betsy F. Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard Page
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jay A. Schrier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yeong Woo Jo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ge Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michelle DeLuca
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Henry C. Vasconez
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Patrick P. DeLuca
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Woo, B.H., Fink, B.F., Page, R. et al. Enhancement of Bone Growth by Sustained Delivery of Recombinant Human Bone Morphogenetic Protein-2 in a Polymeric Matrix. Pharm Res 18, 1747–1753 (2001). https://doi.org/10.1023/A:1013382832091

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013382832091

Search

Navigation